Five-year follow-up of patients with type 1 diabetes transplanted with allogeneic islets: the UIC experience
- 18 July 2014
- journal article
- clinical trial
- Published by Springer Nature in Acta Diabetologica
- Vol. 51 (5) , 833-843
Abstract
This report summarizes a 5-year phase 1/2 allogeneic islet transplantation clinical trial conducted at the University of Illinois at Chicago (UIC). Ten patients were enrolled in this single center, open label, and prospective trial in which patients received 1–3 transplants. The first four subjects underwent islet transplantation with the Edmonton immunosuppressive regimen and the remaining six subjects received the UIC immunosuppressive protocol (Edmonton plus etanercept and exenatide). All 10 patients achieved insulin independence after 1–3 transplants. At 5 years of follow-up, 6 of the initial 10 patients were free of exogenous insulin. During the follow-up period, 7 of the 10 patients maintained positive C-peptide levels and a composite hypoglycemic score of 0. Most patients maintained HbA1c levels <6.0 % (42.1 mmol/mol) and a significantly improved β-score. In conclusion, this study demonstrated long-term islet graft function without using T cell depleting induction, with an encouraging outcome that includes 60 % of patients remaining insulin independent after 5 years of initial transplantation.Keywords
This publication has 40 references indexed in Scilit:
- Has Time Come for New Goals in Human Islet Transplantation?American Journal of Transplantation, 2008
- Changes in Renal Function after Clinical Islet Transplantation: Four-Year Observational StudyAmerican Journal of Transplantation, 2007
- Albumin-to-Creatinine Ratio in Random Urine Samples Might Replace 24-h Urine Collections in Screening For Micro- and Macroalbuminuria in Pregnant Woman With Type 1 DiabetesDiabetes Care, 2006
- Proteinuria Developing After Clinical Islet Transplantation Resolves with Sirolimus Withdrawal and Increased Tacrolimus DosingAmerican Journal of Transplantation, 2005
- Five-Year Follow-Up After Clinical Islet TransplantationDiabetes, 2005
- Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimusNephrology Dialysis Transplantation, 2005
- β-ScoreDiabetes Care, 2005
- Effect of Sirolimus Withdrawal in Patients with Deteriorating Renal FunctionAmerican Journal of Transplantation, 2004
- Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass.Diabetes, 1998
- Sensitization to HLA antigens in islet recipients with failing transplantsTransplantation Proceedings, 1997